Potent inhibitors of lipoprotein-associated phospholipase A2: Benzaldehyde O-heterocycle-4-carbonyloxime

Add time:08/27/2019    Source:sciencedirect.com

A series of multi-substituted oximes were prepared and their potencies for inhibiting lipoprotein-associated phospholipase A2 (Lp-PLA2) activity were evaluated in vitro. Among them, compounds 3a, 3b, and 3m were identified to display a micromolar potency for inhibiting Lp-PLA2 in whole human plasma and isolated human LDL. Based on these results, structure–activity relationship was studied on modification of three parts of R1, R2, and R3 to identify a potent pharmacophore for Lp-PLA2. In an attempt to introduce various functional groups at R2 and R3, we discovered that replacement of less lipophilic groups led to an increase of inhibitory activity. Among the tested oxime derivatives, cyano- and morpholino-substituted analogue 4f at R2 and R3 had the highest potency with an IC50 value of 0.05 μM in whole human plasma.

We also recommend Trading Suppliers and Manufacturers of 2,3-DIFLUORO BENZALDEHYDE OXIME (cas 18355-77-6). Pls Click Website Link as below: cas 18355-77-6 suppliers

Prev:Investigation of intermolecular hydrogen bonding in 2,3,4,5,6 pentafluorobenzoic acid through molecular structure and vibrational analysis – A DFT approach
Next:Short communicationX-ray crystal structure, dipole moment and theoretical molecular orbital study of the cognition activator dihydro-1H-pyrrolizine-3,5(2H, 6H)-dione (‘Rolziracetam (cas 18356-28-0)’)Structure cristalline par diffraction des rayons X, moment électrique et étude théorique par la méthode des orbitales moléculaires du facteur d'acquisition de connaissances dioxo-3,5 pyrrolizidine (⪡rolziracétam⪢))